Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 12-May-22 9:03 PM View:  | Valeant Pharmaceuticals Int... (BHC) | 10-May-22 | Option Exercise | 22,235 | -- | -- | 25% 90.51K to 112.74K | |
| 15-Apr-22 4:32 PM View: | Valeant Pharmaceuticals Int... (BHC) | 14-Apr-22 | Market Sale (Planned) | 1,595 | $22.19 | $35,393.10 | (2%) 92.1K to 90.51K | 2% |
| 16-Mar-22 4:39 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Mar-22 | Market Sale (Planned) | 4,846 | $22.20 | $107,581.00 | (5%) 96.95K to 92.1K | 2% |
| 07-Mar-22 5:49 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-22 | Payment of Exercise | 4,074 | $23.61 | $96,187.10 | (4%) 101.02K to 96.95K | |
| 04-Mar-22 4:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-22 | Grant | 35,627 | $24.17 | $861,105.00 | 53% 66.99K to 102.62K | (10%) |
| 04-Mar-22 4:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Mar-22 | Private Sale (Planned) | 1,595 | $23.37 | $37,275.20 | (2%) 102.62K to 101.02K | |
| 02-Mar-22 9:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Payment of Exercise | 7,297 | $24.35 | $177,682.00 | (10%) 74.29K to 66.99K | |
| 02-Mar-22 9:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Feb-22 | Option Exercise | 15,615 | -- | -- | 27% 58.67K to 74.29K | |
| 02-Mar-22 9:08 PM View: | Valeant Pharmaceuticals Int... (BHC) | 26-Feb-22 | Payment of Exercise | 1,628 | $24.35 | $39,641.80 | (2%) 70.27K to 68.64K | |
| 17-Feb-22 4:36 PM View: | Valeant Pharmaceuticals Int... (BHC) | 15-Feb-22 | Private Sale (Planned) | 3,251 | $25.02 | $81,340.00 | (5%) 63.55K to 60.3K | |
| 20-Jan-22 7:55 PM View: | Valeant Pharmaceuticals Int... (BHC) | 18-Jan-22 | Private Sale (Planned) | 3,251 | $26.63 | $86,574.10 | (5%) 66.8K to 63.55K | |
| 05-Oct-21 4:36 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Oct-21 | Payment of Exercise | 283 | $28.60 | $8,093.80 | (< 1%) 67.08K to 66.8K | |
| 03-Sep-21 10:00 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Sep-21 | Grant | 9,026 | -- | -- | 16% 58.06K to 67.08K | |
| 31-Aug-21 4:09 PM View: | Valeant Pharmaceuticals Int... (BHC) | 27-Aug-21 | Payment of Exercise | 1,278 | $28.95 | $36,998.10 | (2%) 59.34K to 58.06K | |
| 05-Mar-21 6:03 PM View: | Valeant Pharmaceuticals Int... (BHC) | 03-Mar-21 | Grant | 23,892 | -- | -- | 67% 35.44K to 59.34K | |
| 03-Mar-21 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 01-Mar-21 | Payment of Exercise | 3,252 | $31.42 | $102,178.00 | (8%) 38.7K to 35.44K | |
| 06-Oct-20 4:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 02-Oct-20 | Payment of Exercise | 276 | $15.89 | $4,385.64 | (< 1%) 38.97K to 38.7K | |
| 31-Aug-20 6:50 PM View: | Valeant Pharmaceuticals Int... (BHC) | 28-Aug-20 | Payment of Exercise | 1,278 | $17.00 | $21,726.00 | (3%) 40.25K to 38.97K |